• Skip to content (access key 1)
  • Skip to search (access key 7)
FWF — Austrian Science Fund
  • Go to overview page Discover

    • Research Radar
      • Research Radar Archives 1974–1994
    • Discoveries
      • Emmanuelle Charpentier
      • Adrian Constantin
      • Monika Henzinger
      • Ferenc Krausz
      • Wolfgang Lutz
      • Walter Pohl
      • Christa Schleper
      • Elly Tanaka
      • Anton Zeilinger
    • Impact Stories
      • Verena Gassner
      • Wolfgang Lechner
      • Georg Winter
    • scilog Magazine
    • Austrian Science Awards
      • FWF Wittgenstein Awards
      • FWF ASTRA Awards
      • FWF START Awards
      • Award Ceremony
    • excellent=austria
      • Clusters of Excellence
      • Emerging Fields
    • In the Spotlight
      • 40 Years of Erwin Schrödinger Fellowships
      • Quantum Austria
    • Dialogs and Talks
      • think.beyond Summit
    • Knowledge Transfer Events
    • E-Book Library
  • Go to overview page Funding

    • Portfolio
      • excellent=austria
        • Clusters of Excellence
        • Emerging Fields
      • Projects
        • Principal Investigator Projects
        • Principal Investigator Projects International
        • Clinical Research
        • 1000 Ideas
        • Arts-Based Research
        • FWF Wittgenstein Award
      • Careers
        • ESPRIT
        • FWF ASTRA Awards
        • Erwin Schrödinger
        • doc.funds
        • doc.funds.connect
      • Collaborations
        • Specialized Research Groups
        • Special Research Areas
        • Research Groups
        • International – Multilateral Initiatives
        • #ConnectingMinds
      • Communication
        • Top Citizen Science
        • Science Communication
        • Book Publications
        • Digital Publications
        • Open-Access Block Grant
      • Subject-Specific Funding
        • AI Mission Austria
        • Belmont Forum
        • ERA-NET HERA
        • ERA-NET NORFACE
        • ERA-NET QuantERA
        • ERA-NET TRANSCAN
        • Alternative Methods to Animal Testing
        • European Partnership Biodiversa+
        • European Partnership BrainHealth
        • European Partnership ERA4Health
        • European Partnership ERDERA
        • European Partnership EUPAHW
        • European Partnership FutureFoodS
        • European Partnership OHAMR
        • European Partnership PerMed
        • European Partnership Water4All
        • Gottfried and Vera Weiss Award
        • netidee SCIENCE
        • Herzfelder Foundation Projects
        • Quantum Austria
        • Rückenwind Funding Bonus
        • WE&ME Award
        • Zero Emissions Award
      • International Collaborations
        • Belgium/Flanders
        • Germany
        • France
        • Italy/South Tyrol
        • Japan
        • Luxembourg
        • Poland
        • Switzerland
        • Slovenia
        • Taiwan
        • Tyrol–South Tyrol–Trentino
        • Czech Republic
        • Hungary
    • Step by Step
      • Find Funding
      • Submitting Your Application
      • International Peer Review
      • Funding Decisions
      • Carrying out Your Project
      • Closing Your Project
      • Further Information
        • Integrity and Ethics
        • Inclusion
        • Applying from Abroad
        • Personnel Costs
        • PROFI
        • Final Project Reports
        • Final Project Report Survey
    • FAQ
      • Project Phase PROFI
      • Project Phase Ad Personam
      • Expiring Programs
        • Elise Richter and Elise Richter PEEK
        • FWF START Awards
  • Go to overview page About Us

    • Mission Statement
    • FWF Video
    • Values
    • Facts and Figures
    • Annual Report
    • What We Do
      • Research Funding
        • Matching Funds Initiative
      • International Collaborations
      • Studies and Publications
      • Equal Opportunities and Diversity
        • Objectives and Principles
        • Measures
        • Creating Awareness of Bias in the Review Process
        • Terms and Definitions
        • Your Career in Cutting-Edge Research
      • Open Science
        • Open-Access Policy
          • Open-Access Policy for Peer-Reviewed Publications
          • Open-Access Policy for Peer-Reviewed Book Publications
          • Open-Access Policy for Research Data
        • Research Data Management
        • Citizen Science
        • Open Science Infrastructures
        • Open Science Funding
      • Evaluations and Quality Assurance
      • Academic Integrity
      • Science Communication
      • Philanthropy
      • Sustainability
    • History
    • Legal Basis
    • Organization
      • Executive Bodies
        • Executive Board
        • Supervisory Board
        • Assembly of Delegates
        • Scientific Board
        • Juries
      • FWF Office
    • Jobs at FWF
  • Go to overview page News

    • News
    • Press
      • Logos
    • Calendar
      • Post an Event
      • FWF Informational Events
    • Job Openings
      • Enter Job Opening
    • Newsletter
  • Discovering
    what
    matters.

    FWF-Newsletter Press-Newsletter Calendar-Newsletter Job-Newsletter scilog-Newsletter

    SOCIAL MEDIA

    • LinkedIn, external URL, opens in a new window
    • , external URL, opens in a new window
    • Facebook, external URL, opens in a new window
    • Instagram, external URL, opens in a new window
    • YouTube, external URL, opens in a new window

    SCILOG

    • Scilog — The science magazine of the Austrian Science Fund (FWF)
  • elane login, external URL, opens in a new window
  • Scilog external URL, opens in a new window
  • de Wechsle zu Deutsch

  

Cellular methods for studying Ca2+ channel mutations

Cellular methods for studying Ca2+ channel mutations

Bernhard E. Flucher (ORCID: 0000-0002-5255-4705)
  • Grant DOI 10.55776/P16532
  • Funding program Principal Investigator Projects
  • Status ended
  • Start September 1, 2003
  • End February 28, 2007
  • Funding amount € 334,002
  • Project website

Disciplines

Biology (20%); Medical-Theoretical Sciences, Pharmacy (80%)

Keywords

    Skeletal Muscle, Calcium Channel, Dihydropyridine Receptor, Ryanodine Receptor, Malignant Hyperthermia, Cell Culture

Abstract Final report

Previously we have developed a muscle cell culture system, which allowed us to study the structure and function of genetically altered ion channels in their native cellular environment. This system proved to be of exceptional value for investigations of the role of calcium (Ca 2+) channels in the activation of muscle contraction - a process termed excitation-contraction (EC-) coupling. Here we propose to develop several new cell culture systems, which will extend this successful research strategy to a broader range of Ca2+ channels in muscle and nerve cells, and to the study of human disease mutations. It can be expected that these "homologous expression systems" will greatly contribute to basic and applied research in the field of EC-coupling, while at the same time reducing the need of animal experimentation. The novel approach of generating the cell lines is by cross-breeding available spontaneous null-mutant or knock- out mice, which lack an important Ca2+ channel, with the so-called ImmortoMouse. Cells derived from these mouse hybrids can be expanded over many generations under permissive culture conditions but undergo normal differentiation under non-permissive conditions. These properties make such cell lines suitable for stable transfection with recombinant Ca2+ channel constructs. Transfection with cDNA coding for the lacking wild-type channel restores normal function in the mutant muscle cells. Moreover, reconstitution of the deficient muscle cells with mutant channels enables us to analyze the effects of the experimentally introduced mutations on muscle development and function using a broad range of methods. This will yield important information on the properties of the Ca2+ channels, on the mechanism of EC-coupling, and on the pathophysiology of muscle disease. In order to assess the full potential of these cultures as cellular disease models, two cell lines expressing Ca2+ channel mutants, which in humans cause malignant hyperthermia, will be generated and analyzed in our own and several collaborating laboratories. Furthermore, we plan to generate null-mutant cell lines from brain tissue of the same mouse hybrids. Thus, this valuable approach to study Ca2+ channel mutants that has hitherto been limited to muscle cells shall now also be made possible for neurons.

The overall goal of this project was to develop new cellular expression models of muscle cells to study the structure and function of normal and mutant calcium channels in their native environment. To this end we cross- bred mice lacking the skeletal muscle calcium channels with the Immortomouse and isolated myoblasts which combined the properties of both mouse mutants. To allow genotyping of the mutant mice the position of the transgene in the genome of the Immortomice was identified and PCR-based assays were developed (Kern & Flucher, 2005). Using this approach several CaV1.1 and RyR1 calcium channel null-mutant cell lines were generated, and the potential to restore normal function by heterologous expression of the healthy copies of the affected genes was examined. Thorough characterization of these stably transfected muscle cell lines demonstrated an unexpected clone-to-clone variability in the properties of the muscle cell lines that precluded meaningful analysis of calcium channel disease mutants. In contrast, transient transfection of immortalized null-mutant cell lines proved to be suitable for investigation of structure-function relationships of mutated calcium channels (Kugler et al., 2004a and b; Weiss et al., 2004; Takekura et al., 2004; Schuhmeier et al., 2005). As an alternative to studying altered calcium channel function in reconstituted null-mutant cell lines, we investigated the effectiveness of siRNA gene silencing in striated muscle cells. This novel approach proved particularly useful for studying essential proteins for which knock-out animals are not viable. Therefore we used siRNA for the first time in muscle cells in a study of the function of the calcium channel a 2 d-1 subunit in controlling skeletal and cardiac muscle contraction (Obermair et al., 2004, 2005; Tuluc et al., 2007). Reconstituting our null-mutant muscle cell lines with the cardiac calcium channel a 1C subunit restored cardiac excitation- contraction coupling properties in the skeletal muscle system. Simulating the experimentally obtained effects of a 2 d-1 depletion in a computer model of cardiac myocytes indicated a disease-relevant prolongation of the cardiac action potential (Tuluc et al., 2007). Combining our unique null-mutant muscle cell systems with recombinant expression and siRNA techniques and, where applicable, with state-of-the-art computer models of heart cells, provides a powerful novel approach to investigate the consequences of experimental and disease mutation in the calcium channel genes on normal skeletal and cardiac muscle function. Thus, the new cell models and experimental strategies developed in the course of this project aid in understanding the calcium channel functions in normal and diseased muscle cells, and provide a valuable alternative to generating and experimentation with genetically modified animal models.

Research institution(s)
  • Medizinische Universität Innsbruck - 100%
International project participants
  • Thomas V. Mccarthy, University College Cork - Ireland
  • Vincenzo Sorrentino, Università degli studi di Padova - Italy
  • Robert T. Dirksen, University of Rochester - USA

Research Output

  • 324 Citations
  • 8 Publications
Publications
  • 2007
    Title Computer modeling of siRNA knockdown effects indicates an essential role of the Ca2+ channel a2d-1 subunit in cardiac excitation–contraction coupling
    DOI 10.1073/pnas.0700577104
    Type Journal Article
    Author Tuluc P
    Journal Proceedings of the National Academy of Sciences
    Pages 11091-11096
    Link Publication
  • 2005
    Title The ß1a subunit is essential for the assembly of dihydropyridine-receptor arrays in skeletal muscle
    DOI 10.1073/pnas.0508710102
    Type Journal Article
    Author Schredelseker J
    Journal Proceedings of the National Academy of Sciences
    Pages 17219-17224
    Link Publication
  • 2008
    Title SRP-27 is a novel component of the supramolecular signalling complex involved in skeletal muscle excitation–contraction coupling
    DOI 10.1042/bj20070906
    Type Journal Article
    Author Bleunven C
    Journal Biochemical Journal
    Pages 343-349
    Link Publication
  • 2005
    Title Localization of transgenes and genotyping of H-2Kb-tsA58 transgenic mice
    DOI 10.2144/05381bm03
    Type Journal Article
    Author Kern G
    Journal BioTechniques
    Pages 38-42
    Link Publication
  • 2005
    Title The role of auxiliary dihydropyridine receptor subunits in muscle
    DOI 10.1007/s10974-005-9000-2
    Type Journal Article
    Author Flucher B
    Journal Journal of Muscle Research & Cell Motility
    Pages 1-6
  • 2004
    Title Functional Interaction of CaV Channel Isoforms with Ryanodine Receptors Studied in Dysgenic Myotubes
    DOI 10.1529/biophysj.104.051318
    Type Journal Article
    Author Schuhmeier R
    Journal Biophysical Journal
    Pages 1765-1777
    Link Publication
  • 2004
    Title Differential Contribution of Skeletal and Cardiac II-III Loop Sequences to the Assembly of Dihydropyridine-Receptor Arrays in Skeletal Muscle
    DOI 10.1091/mbc.e04-05-0414
    Type Journal Article
    Author Takekura H
    Journal Molecular Biology of the Cell
    Pages 5408-5419
    Link Publication
  • 2004
    Title The monoclonal antibody mAB 1A binds to the excitation–contraction coupling domain in the II–III loop of the skeletal muscle calcium channel a1S subunit
    DOI 10.1016/j.abb.2004.04.007
    Type Journal Article
    Author Kugler G
    Journal Archives of Biochemistry and Biophysics
    Pages 91-100

Discovering
what
matters.

Newsletter

FWF-Newsletter Press-Newsletter Calendar-Newsletter Job-Newsletter scilog-Newsletter

Contact

Austrian Science Fund (FWF)
Georg-Coch-Platz 2
(Entrance Wiesingerstraße 4)
1010 Vienna

office(at)fwf.ac.at
+43 1 505 67 40

General information

  • Job Openings
  • Jobs at FWF
  • Press
  • Philanthropy
  • scilog
  • FWF Office
  • Social Media Directory
  • LinkedIn, external URL, opens in a new window
  • , external URL, opens in a new window
  • Facebook, external URL, opens in a new window
  • Instagram, external URL, opens in a new window
  • YouTube, external URL, opens in a new window
  • Cookies
  • Whistleblowing/Complaints Management
  • Accessibility Statement
  • Data Protection
  • Acknowledgements
  • IFG-Form
  • Social Media Directory
  • © Österreichischer Wissenschaftsfonds FWF
© Österreichischer Wissenschaftsfonds FWF